Medroxyprogesterone Acetate | Greenstone Llc Breastfeeding
Modern medicine has evolved so much so that sooner or later every breastfeeding mother needs to take it in one form or other. Medication that is present in mothers blood will transfer into her breast milk to some extent. Most drugs do so at low levels and pose no real risk to infants but then there are some exceptions. In This post will discuss whether Medroxyprogesterone Acetate | Greenstone Llc is safe in breast-feeding or not.

What is Medroxyprogesterone Acetate | Greenstone Llc used for?

Medroxyprogesterone acetate tablets are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. They are also indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving daily oral conjugated estrogens 0.625 mg tablets.

I am currently breastfeeding and I want to know if using Medroxyprogesterone Acetate | Greenstone Llc is safe for my kid? Does it have any effect on milk production?

Medroxyprogesterone Acetate | Greenstone Llc safe for breastfeeding
As per our analysis Medroxyprogesterone Acetate | Greenstone Llc contains only one ingredient and that is Medroxyprogesterone acetate. We have analyzed Medroxyprogesterone acetate and it seems to be safe to use Medroxyprogesterone acetate while breastfeeding, that means usage of Medroxyprogesterone Acetate | Greenstone Llc shall be safe while breastfeeding. Below you can check more details of Medroxyprogesterone acetate usage in breastfeeding. We recommend you to go through provided detailed analysis as below take decision accordingly.

Statement of Manufacturer/Labeler about breastfeeding usage
F. Nursing Mothers MPA tablets should not be used during lactation. Detectable amounts of progestin have been identified in the breast milk of nursing mothers receiving progestins.

Medroxyprogesterone Acetate | Greenstone Llc Breastfeeding Analsys

Medroxyprogesterone acetate while Breastfeeding


CAS Number: 71-58-9

Medroxyprogesterone Acetate | Greenstone Llc and breastfeeding

Synthetic progestin similar to progesterone that is used in uterine bleeding, dysmenorrhea, infertility and contraception.For contraception is used as a single drug or in combination with estrogen (e.g. Estradiol + Medroxyprogesterone).For oral use or long-acting injectable administration (Intramuscular or subcutaneous). It is excreted into breast milk in clinically non-significant amount, and, no problems have been observed in infants whose mothers who were treated with this medication. Plasma levels of these infants were undetectable or very low.There may be increased prolactin and milk production in women who receive medroxyprogesterone. Although it has not been shown effects on production and duration of breastfeeding when administered at any time postpartum, it is still controversial on if it really decreases milk production when progestins are used before a fully establishment of breastfeeding has occurred. Therefore, experts’ protocols by WHO and ABM advise to avoiding it until breastfeeding is fully developed (4-6 weeks). During lactation progestin-only drugs are preferred or in combination with estrogen for birth control, but whatever, the ones with the lower doses of estrogen should be used.For the first 6 weeks postpartum, non-hormonal methods are of choise. Hormone containing contraceptives do not affect the composition of milk, minerals (Mg, Fe, Cu, Ca, P) fat, lactose and calories but only a few the proteins. WHO List of Essential Medicines 2002: rates it as compatible with breastfeeding after the 6th postnatal week.

Medroxyprogesterone Acetate | Greenstone Llc Breastfeeding Analsys - 2

Medroxyprogesterone acetate while Breastfeeding

CAS Number: 71-58-9

Is Medroxyprogesterone Acetate | Greenstone Llc safe while breastfeeding

Although nonhormonal methods are preferred during breastfeeding, progestin-only contraceptives such as depot medroxyprogesterone acetate (DMPA) are considered the hormonal contraceptives of choice during all stages of lactation. Fair quality evidence indicates that DMPA does not adversely affect the composition of milk, the growth and development of the infant, or the milk supply.[1][2][3][4] Some evidence indicates that progestin-only contraceptives may offer protection against bone mineral density loss during lactation, or at least do not exacerbate it.[5][6][7] The timing of initiation of DMPA is controversial.[8] The product labeling states that it should be started no sooner than 6 weeks postpartum, based on data submitted for product approval. Studies of fair quality seem to indicate that concerns about immediate adverse effects on the infants is unfounded; however, starting too soon theoretically could affect the newborn infant adversely because of slower metabolism of the drug than older infants. Of concern is that no data exist on the effects of progesterone on brain and liver development at this age. Administration sooner than 6 weeks postpartum could interfere with the exclusivity or duration of lactation. A systematic review of studies using early postpartum initiation of DMPA concluded that all of the studies were of low quality and inadequate to disprove the concern about DMPA's effects on milk production if given sooner than 6 weeks after delivery.[9] A subsequent study raised the possibility of a slight reduction in breastfeeding duration in women given DMPA before hospital discharge,[10] and another study found that breastfeeding was less like to be initiated if mothers received immediate postpartum DMPA.[11] Expert opinion in the United States holds that the risks of progestin-only contraceptive products usually are acceptable for nursing mothers at any time postpartum.[12]The World Health Organization recommends that injectable depot medroxyprogesterone acetate should not used before 6 weeks postpartum.[13]

Medroxyprogesterone Acetate | Greenstone Llc safe for breastfeeding

I am nursing mother and I have already used Medroxyprogesterone Acetate | Greenstone Llc, what should I do?

Medroxyprogesterone Acetate | Greenstone Llc is safe in breastfeeding and should not create any health problem for your baby but in case you feel any health issue associated with Medroxyprogesterone Acetate | Greenstone Llc you should contact your doctor or health care provider. Be it pregnancy or lactation you shall keep your doctor informed.

My health care provider has asked me to use Medroxyprogesterone Acetate | Greenstone Llc, what to do?

Definitely, Medroxyprogesterone Acetate | Greenstone Llc is safe in lactation for baby. No wonder your doctor has recommended it.

If I am using Medroxyprogesterone Acetate | Greenstone Llc, will my baby need extra monitoring?

No extra baby monitoring required while mother is using Medroxyprogesterone Acetate | Greenstone Llc

Who can I talk to if I have questions about usage of Medroxyprogesterone Acetate | Greenstone Llc in breastfeeding?

National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week